Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-I Wang

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Bioconjugate Chemistry|November 11, 2017
Imaging PD-L1 Expression with ImmunoPETCharles Truillet, Hsueh Ling J Oh, Siok Ping Yeo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 30, 2024
Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1)Yun Shan Goh, Siew-Wai Fong, Pei Xiang Hor, et al.
Nature Communications|June 3, 2020
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patientsChek Meng Poh, Guillaume Carissimo, Bei Wang, et al.
Biorxiv : the Preprint Server for Biology|July 24, 2020
Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralizationBei Wang, Daniel Asarnow, Wen-Hsin Lee, et al.
Cell Reports. Medicine|January 26, 2021
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, et al.
EMBO Molecular Medicine|May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Clinical & Translational Immunology|February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variantCheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Frontiers in Immunology|December 1, 2022
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individualsYun Shan Goh, Angeline Rouers, Siew-Wai Fong, et al.
Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Bioconjugate Chemistry|November 11, 2017
Imaging PD-L1 Expression with ImmunoPETCharles Truillet, Hsueh Ling J Oh, Siok Ping Yeo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 30, 2024
Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1)Yun Shan Goh, Siew-Wai Fong, Pei Xiang Hor, et al.
Nature Communications|June 3, 2020
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patientsChek Meng Poh, Guillaume Carissimo, Bei Wang, et al.
Biorxiv : the Preprint Server for Biology|July 24, 2020
Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralizationBei Wang, Daniel Asarnow, Wen-Hsin Lee, et al.
Cell Reports. Medicine|January 26, 2021
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, et al.
EMBO Molecular Medicine|May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Clinical & Translational Immunology|February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variantCheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Frontiers in Immunology|December 1, 2022
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individualsYun Shan Goh, Angeline Rouers, Siew-Wai Fong, et al.
Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.
Pageof 6